Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other Accumulated Expenses (2016 - 2025)

Haemonetics has reported Other Accumulated Expenses over the past 16 years, most recently at $134.3 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $134.3 million for Q4 2025, down 3.52% from a year ago — trailing twelve months through Dec 2025 was $134.3 million (down 3.52% YoY), and the annual figure for FY2025 was $148.1 million, up 8.85%.
  • Other Accumulated Expenses for Q4 2025 was $134.3 million at Haemonetics, roughly flat from $134.0 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for HAE hit a ceiling of $150.0 million in Q3 2024 and a floor of $85.3 million in Q3 2022.
  • Median Other Accumulated Expenses over the past 5 years was $130.1 million (2021), compared with a mean of $125.9 million.
  • Biggest five-year swings in Other Accumulated Expenses: soared 41.93% in 2021 and later crashed 33.26% in 2022.
  • Haemonetics' Other Accumulated Expenses stood at $119.7 million in 2021, then decreased by 15.63% to $101.0 million in 2022, then skyrocketed by 31.12% to $132.4 million in 2023, then grew by 5.15% to $139.2 million in 2024, then dropped by 3.52% to $134.3 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $134.3 million (Q4 2025), $134.0 million (Q3 2025), and $145.6 million (Q2 2025) per Business Quant data.